NCT02226081

Brief Summary

We aim to determine if adding ShearWave Elastography to a standard ultrasound breast exam can improve the characterization (classification) of breast lesions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,273

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2014

Shorter than P25 for all trials

Geographic Reach
1 country

22 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 25, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 26, 2014

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
Last Updated

December 20, 2018

Status Verified

December 1, 2018

Enrollment Period

1 year

First QC Date

August 25, 2014

Last Update Submit

December 18, 2018

Conditions

Keywords

breast lesionultrasoundBI-RADSwomenmalignancy

Outcome Measures

Primary Outcomes (1)

  • Increase in specificity of breast ultrasound imaging when considering stiffness measurements

    Within 18 months of the study start date

Secondary Outcomes (2)

  • Change of sensitivity and negative predictive value of breast ultrasound imaging when considering stiffness measurements

    Within 18 months of the study start date

  • Increase in positive predictive value for biopsy of breast ultrasound when considering stiffness measurements

    within 18 months of the study start date

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Chinese women (age of majority) who have been referred to a hospital or clinical for a breast ultrasound evaluation.

You may qualify if:

  • female
  • years of age or older
  • known breast lesion that has not been managed or treated
  • referred for a breast ultrasound because of a breast mass found on at least one of the following examinations:
  • physical palpation
  • mammography
  • ultrasound exam
  • MRI

You may not qualify if:

  • Women who are unwilling or unable to provide informed consent
  • Women with breast implants
  • Women who are pregnant or breastfeeding
  • Women in whom all lesions are diagnostically categorized as BI-RADS 0, 1 or 6
  • Women with previous ipsilateral breast surgery
  • Women with no visible breast mass on ultrasound examination
  • Women with axillary metastatic lymph nodes only
  • Women with foreign body in the breast
  • Women who are not Chinese nationality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (22)

1st Affiliated Hospital of PLAGH (304)

Beijing, China

Location

Beijing Friendship Hospital, Capital Medical University

Beijing, China

Location

People's Liberation Army General Hospital (301)

Beijing, China

Location

Affiliated Hospital of Binzhou Medical University

Binzhou, China

Location

Sichuan Provincial People's Hospital

Chengdu, China

Location

West China Hospital, Sichuan University

Chengdu, China

Location

Fujian Provincial Cancer Hospital

Fuzhou, China

Location

Guangdong Provincial Traditional Chinese Medical Hospital

Guangzhou, China

Location

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

Guangzhou, China

Location

Sun-Yat Sen University Cancer Center

Guangzhou, China

Location

1st Affiliated Hospital of Harbin University

Harbin, China

Location

Hefei 2nd People's Hospital

Hefei, China

Location

Jiangsu Provincial Hospital

Nanjing, China

Location

Yinzhou People's Hospital

Ningbo, China

Location

Fudan University Cancer Center

Shanghai, China

Location

1st Affiliated Hospital of China Medical University

Shenyang, China

Location

4th Affiliated Hospital of China Medical University

Shenyang, China

Location

Shengjing Hospital of China Medical University

Shenyang, China

Location

General Hospital of TISCO

Taiyuan, China

Location

Shanxi Dayi Hospital

Taiyuan, China

Location

1st Affiliated Hospital of Xi'an Jiaotong University

Xi'an, China

Location

1st Affiliated Hospital of Zhengzhou University

Zhengzhou, China

Location

Related Publications (1)

  • Lin X, Chang C, Wu C, Chen Q, Peng Y, Luo B, Tang L, Li J, Zheng J, Zhou R, Cui G, Li A, Wang X, Qian L, Zhang J, Wen C, Gay J, Zhang H, Li A, Chen Y. Confirmed value of shear wave elastography for ultrasound characterization of breast masses using a conservative approach in Chinese women: a large-size prospective multicenter trial. Cancer Manag Res. 2018 Oct 11;10:4447-4458. doi: 10.2147/CMAR.S174690. eCollection 2018.

Related Links

MeSH Terms

Conditions

Breast NeoplasmsNeoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Cai Chang

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Anhua Li

    Sun Yat-sen University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 25, 2014

First Posted

August 26, 2014

Study Start

June 1, 2014

Primary Completion

June 1, 2015

Study Completion

June 1, 2015

Last Updated

December 20, 2018

Record last verified: 2018-12

Locations